Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meera Chitlur

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Research and Practice in Thrombosis and Haemostasis|January 31, 2024
Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSCPaolo Gresele, Emanuela Falcinelli, Loredana Bury, et al.
Clinical Pharmacokinetics|August 23, 2019
Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate<sup>®</sup>): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc SubgroupPierre Chelle, Cindy H T Yeung, Stacy E Croteau, et al.
Blood Vessels, Thrombosis & Hemostasis|July 1, 2026
Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 studyTammuella Chrisentery-Singleton, Suchitra Acharya, Sanjay Ahuja, et al.
Expert Review of Hematology|March 15, 2023
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophiliaDuc Q Tran, Craig C Benson, Judith A Boice, et al.
Research Square|October 27, 2023
A Scan of Pleiotropic Immune Mediated Disease Genes Identifies Novel Determinants of Baseline FVIII Inhibitor Status in Hemophilia-ATom Howard, Marcio Almieda, Vincent Diego, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 27, 2022
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitorsSteven W Pipe, Cédric Hermans, Meera Chitlur, et al.
Journal of Thrombosis and Haemostasis : JTH|June 18, 2023
Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet PhysiologyMarie-Christine Alessi, Carmen Coxon, Manal Ibrahim-Kosta, et al.
Genes and Immunity|April 22, 2025
A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia AMarcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
Genes and Immunity|September 25, 2025
Correction: A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia AMarcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Research and Practice in Thrombosis and Haemostasis|January 31, 2024
Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSCPaolo Gresele, Emanuela Falcinelli, Loredana Bury, et al.
Clinical Pharmacokinetics|August 23, 2019
Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate<sup>®</sup>): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc SubgroupPierre Chelle, Cindy H T Yeung, Stacy E Croteau, et al.
Blood Vessels, Thrombosis & Hemostasis|July 1, 2026
Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 studyTammuella Chrisentery-Singleton, Suchitra Acharya, Sanjay Ahuja, et al.
Expert Review of Hematology|March 15, 2023
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophiliaDuc Q Tran, Craig C Benson, Judith A Boice, et al.
Research Square|October 27, 2023
A Scan of Pleiotropic Immune Mediated Disease Genes Identifies Novel Determinants of Baseline FVIII Inhibitor Status in Hemophilia-ATom Howard, Marcio Almieda, Vincent Diego, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 27, 2022
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitorsSteven W Pipe, Cédric Hermans, Meera Chitlur, et al.
Journal of Thrombosis and Haemostasis : JTH|June 18, 2023
Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet PhysiologyMarie-Christine Alessi, Carmen Coxon, Manal Ibrahim-Kosta, et al.
Genes and Immunity|April 22, 2025
A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia AMarcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
Genes and Immunity|September 25, 2025
Correction: A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia AMarcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
Pageof 6